|

tumor-specific TCR-T cells Clinical Trials

1 actively recruiting trial

Also known as: FIT-001, TCR-T cells

Pipeline

Phase 1: 1

Top Sponsors

  • Guangzhou FineImmune Biotechnology Co., LTD.1

Indications

  • Solid Tumor1
  • Cancer1

Other1 trial

Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.